To prevent nonalcoholic fatty liver disease - the most common cause of chronic liver disease worldwide - in mice, researchers have discovered a way.
According to investigators at Washington University School of Medicine in St. Louis, blocking a path that delivers dietary fructose to the liver prevented mice from developing the condition.
Alcoholic Liver Disease
Encyclopedia section of medindia gives general information about Alcoholic Liver Disease.
Advertisement
First author Brian J. DeBosch, MD, PhD, clinical fellow in pediatric gastroenterology, said that there are competing hypotheses about the origins of metabolic syndrome and one of these hypotheses is that insulin resistance begins to develop in the liver first.
The research team, led by Kelle H. Moley, MD, the James P. Crane Professor of Obstetrics and Gynecology, showed that a molecule called GLUT8 carries large amounts of fructose into liver cells.
![Deadly Complications of Liver Disease can be Prevented by Probiotics]( "Deadly Complications of Liver Disease can be Prevented by Probiotics")
New research suggests that probiotics are effective in preventing hepatic encephalopathy in patients with cirrhosis of the liver.
In this study, researchers showed that blocking or eliminating GLUT8 in mice reduced the amount of fructose entering the organ and appeared to prevent the development of fatty livers. Mice with GLUT8 deficiency also appeared to burn liver fat at a faster rate than control mice.
The researchers also saw differences between male and female mice in the degree to which they were protected from fatty livers and in whole-body metabolism. Male mice fed a high-fructose diet while deficient in GLUT8 still had evidence of fatty liver disease, but whole-body metabolism was healthy.
They showed no evidence of metabolic syndrome in the rest of the body. Females fed fructose while lacking GLUT8, in contrast, had healthy looking livers but exhibited more evidence of whole-body metabolic syndrome.
The study has been published in The Journal of Biological Chemistry.
Source: ANI
Deadly Complications of Liver Disease can be Prevented by Probiotics
New research suggests that probiotics are effective in preventing hepatic encephalopathy in patients with cirrhosis of the liver.
Advertisement
In this study, researchers showed that blocking or eliminating GLUT8 in mice reduced the amount of fructose entering the organ and appeared to prevent the development of fatty livers. Mice with GLUT8 deficiency also appeared to burn liver fat at a faster rate than control mice.
The researchers also saw differences between male and female mice in the degree to which they were protected from fatty livers and in whole-body metabolism. Male mice fed a high-fructose diet while deficient in GLUT8 still had evidence of fatty liver disease, but whole-body metabolism was healthy.
They showed no evidence of metabolic syndrome in the rest of the body. Females fed fructose while lacking GLUT8, in contrast, had healthy looking livers but exhibited more evidence of whole-body metabolic syndrome.
The study has been published in The Journal of Biological Chemistry.
Source: ANI
Higher Mortality Rate in Lean Patients With Fatty Liver Disease
Lean patients with nonalcoholic fatty liver disease have higher overall mortality rate than obese persons, despite being of a healthier weight, reports a new research.
Advertisement
 Steroids Ineffective and Possibly Harmful in Pediatric Liver DiseaseTreating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia, says a new study. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.